Ivan Sloma

Associate professor (MCU-PH)

Sorbonne Université Faculté de Médecine

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ivan Sloma is an Associate Professor at Université Paris Est Créteil - Faculté de Médecine AP-HP, France. His research areas encompass myelodysplastic neoplasms, chronic myelomonocytic leukemia, and hematologic malignancies. Dr. Sloma has contributed significantly to studies on the evolution of myelodysplastic syndromes, the impact of genetic mutations in cancer progression, and innovative methodologies for detecting mutations in hematological disorders.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Damien Luque Paz

FRANCE

View details

Loïc Garçon

FRANCE

View details

Nathalie Droin

Inserm u1183

FRANCE

View details

Olivier Mansier

University of Bordeaux

FRANCE

View details

Jean-Christophe Ianotto

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ivan Sloma

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia

ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: A case‐story with two successive HLA‐matched sibling donors

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia

Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection.

Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients

High prevalence of unusual KRAS, NRAS and BRAF mutations in POLE hypermutated colorectal cancers

Leukaemic evolution of rare donor CSF3R germline mutation after umbilical cord blood transplant

Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression.

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.

Collaborators (5)

Damien Luque Paz

Loïc Garçon

Nathalie Droin

Olivier Mansier

Jean-Christophe Ianotto

Make your next move.